We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

83 hedge funds and large institutions have $390M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

52% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 23

42% more capital invested

Capital invested by funds: $275M → $390M (+$114M)

8% more funds holding

Funds holding: 7783 (+6)

Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
35
Reduced
23
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
51
Two Sigma Advisers
New York
$750K +$136K +9,500 +26%
Wells Fargo
52
Wells Fargo
California
$744K +$65.8K +4,605 +11%
Morgan Stanley
53
Morgan Stanley
New York
$721K -$648K -45,327 -50%
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$635K +$3.67K +257 +0.7%
HP
55
Hound Partners
New York
$524K +$462K +32,302 New
Goldman Sachs
56
Goldman Sachs
New York
$483K -$478K -33,431 -53%
CCIA
57
Campbell & Co Investment Adviser
Maryland
$445K +$392K +27,400 New
Los Angeles Capital Management
58
Los Angeles Capital Management
California
$420K
PCM
59
Prelude Capital Management
New York
$372K +$327K +22,892 New
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$353K -$159K -11,125 -34%
AllianceBernstein
61
AllianceBernstein
Tennessee
$331K +$18.6K +1,300 +7%
Jane Street
62
Jane Street
New York
$322K -$598K -41,837 -68%
KeyBank National Association
63
KeyBank National Association
Ohio
$321K -$614K -42,963 -68%
TI
64
Trexquant Investment
Connecticut
$279K +$246K +17,195 New
AIG
65
American International Group
New York
$273K +$4.33K +303 +2%
Squarepoint
66
Squarepoint
New York
$230K +$43.2K +3,023 +27%
MIM
67
MetLife Investment Management
New Jersey
$203K +$179K +12,520 New
EGM
68
Engineers Gate Manager
New York
$188K +$165K +11,562 New
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$176K
PTC
70
Petrus Trust Company
Texas
$176K +$155K +10,841 New
Barclays
71
Barclays
United Kingdom
$175K +$109K +7,651 +241%
VOYA Investment Management
72
VOYA Investment Management
Georgia
$172K
Bank of Montreal
73
Bank of Montreal
Ontario, Canada
$165K -$71 -5 -0%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$147K +$130K +9,065 New
Citigroup
75
Citigroup
New York
$113K +$47.5K +3,324 +91%

OXFD Hedge Fund Activity: Q3 2018 in Review

83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2018, worth a combined $390M — up 42% from $275M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new OXFD positions and 9 closed out — a net gain of 6 holders — while 35 added to existing stakes and 23 trimmed.

The largest buyer was First Light Asset Management, adding an estimated $5.06M. The largest seller was Axa, exiting entirely with an estimated $6.19M sold.

  • 83 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2018, up from 77 in Q2 2018.
  • Funds reported $390M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2018, up 42% quarter-over-quarter.
  • 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2018 and 9 closed out, a net change of +6 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2018 was First Light Asset Management, an estimated $5.06M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2018 was Axa, an estimated $6.19M sold.

Based on aggregated 13F filings for Q3 2018.